Skip to content

Establish a whole-process medical record management model for neurocognitive impairment graded diagnosis, treatment and rehabilitation based on family and community (Shenzhiling Chinese Medicine Intervention)

Establish a whole-process medical record management model for neurocognitive impairment graded diagnosis, treatment and rehabilitation based on family and community (Shenzhiling Chinese Medicine Intervention)

Status
Recruiting
Phases
Phase 4
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000040022
Enrollment
Unknown
Registered
2020-11-18
Start date
2020-12-01
Completion date
Unknown
Last updated
2021-01-05

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Neurocognitive impairment

Interventions

Sponsors

Shanghai Mental Health Center
Lead Sponsor

Eligibility

Sex/Gender
All
Age
50 Years to 90 Years

Inclusion criteria

Inclusion criteria: Entry criteria 1. Meet the MMSE scale: MMSE 11 to 26 points (subjects with elementary school education MMSE 11 to 22 points); 2. CDR score 0.5-2.0; 3. Comply with the diagnostic criteria of syndromes of deficiency of both heart and spleen in TCM; 4. Geriatric Depression Scale (GDS) <=10 points; 5. Those who have a clear consciousness, volunteer to participate, cooperate with various examinations and treatments, and sign informed consent.

Exclusion criteria

Exclusion criteria: 1. Those who do not meet the above standards or have incomplete data or who have severe neurological impairment (severe hemiplegia, various aphasia, and visual and hearing impairment) or who are unwilling to accept research measures; 2. Those who have other diseases that can cause dysfunction or severe heart, liver, kidney disease or severe mental symptoms; 3. Patients with certain diseases or bad habits that can interfere with the evaluation of cognitive function, including those who add alcohol, drugs, or abuse other psychotropic drugs; 4. Patients suffering from severe indigestion, or gastrointestinal obstruction or other gastrointestinal diseases that affect drug absorption; 5. Those who have taken sedatives, hypnotics, antipsychotics, antidepressants, and central stimulants for a long time, and cannot stop the drug for 1 month before the study; 6. Those who have taken related or antagonistic drugs in the past 1 month, making it difficult to judge the efficacy.

Design outcomes

Primary

MeasureTime frame
Psychobehavioral symptoms;

Secondary

MeasureTime frame
Sleep condition;TCM Syndrome Score;

Countries

China

Contacts

Public ContactXia Li

Shanghai Mental Health Center

ja_1023@aliyun.com+86 13774272543

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026